Education
About Us
Working with TipRanks
Follow Us
Star Combo Pharma Ltd. (AU:S66)
:S66
RESEARCH TOOLSreports
Total Valuation
Star Combo Pharma Ltd. has a market cap or net worth of AU$18.23M. The enterprise value is ―.
Market CapAU$18.23M
Enterprise Value―
Share Statistics
Star Combo Pharma Ltd. has 135,002,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding135,002,980
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Star Combo Pharma Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Star Combo Pharma Ltd. is ―. Star Combo Pharma Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Star Combo Pharma Ltd. had revenue of 26.02M and earned 747.33K in profits. Earnings per share was 0.01.
Revenue26.02M
Gross Profit5.44M
Operating Income723.43K
Pretax Income1.00M
Net Income747.33K
EBITDA2.79M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was -63.54K and capital expenditures -1.75M, giving a free cash flow of -1.82M billion.
Operating Cash Flow-63.54K
Free Cash Flow-1.82M
Free Cash Flow per Share-0.01
Dividends & Yields
Star Combo Pharma Ltd. pays an annual dividend of AU$0.003, resulting in a dividend yield of 2.74%
Dividend Per ShareAU$0.003
Dividend Yield2.74%
Payout Ratio42.86%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.06
52-Week Price Change27.27%
50-Day Moving Average0.14
200-Day Moving Average0.14
Relative Strength Index (RSI)39.28
Average Volume (3m)3.91K
Important Dates
Star Combo Pharma Ltd. upcoming earnings date is Aug 26, 2025, TBA Not Confirmed.
Last Earnings DateFeb 26, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend DateOct 14, 2024
Financial Position
Star Combo Pharma Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Star Combo Pharma Ltd. has paid 253.73K in taxes.
Income Tax253.73K
Effective Tax Rate―
Enterprise Valuation
Star Combo Pharma Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Star Combo Pharma Ltd. has AU$7.36M in cash and marketable securities with AU$4.03M in debt, giving a net cash position of -AU$3.33M billion.
Cash & Marketable SecuritiesAU$7.36M
Total DebtAU$4.03M
Net Cash-AU$3.33M
Net Cash Per Share-AU$0.02
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Star Combo Pharma Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast16.45%
EPS Growth Forecast83.33%